Tenet Healthcare Falls as Hospital Sector Sentiment Sours Ahead of Earnings

Tenet Healthcare (THC) is down 6.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied mainly to pressure across hospital operators rather than a new Tenet-specific announcement. This could be because a large peer flagged weaker payer mix trends and more uninsured patients, which may have raised concerns that similar reimbursement and volume pressures could affect Tenet as investors head toward its late-July earnings report.

Details:

Tenet has not posted a new company-specific press release or filing tied to today’s drop, suggesting the move may be driven more by sector read-through than by fresh internal news.

A major for-profit hospital peer released preliminary second-quarter results and cut full-year guidance, citing a worsening payer mix as more patients lost exchange coverage.

That update appears to have weighed on sentiment for hospital names broadly, with investors reassessing reimbursement quality, uncompensated care risk, and margin durability across the group.

Tenet is scheduled to report second-quarter 2026 results on July 24, which may have amplified caution as traders position ahead of another closely watched earnings release.

Sources:

Tenet Healthcare, CMS, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$THC Insider Trading Activity

$THC insiders have traded $THC stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:

THOMAS W ARNST (EVP, Chief Admin. Officer & GC) has made 0 purchases and 3 sales selling 32,000 shares for an estimated $7,527,737.
R. SCOTT RAMSEY (Principal Accounting Officer) has made 0 purchases and 3 sales selling 8,017 shares for an estimated $1,865,576.
PAOLA M ARBOUR (EVP, Chief Information Officer) sold 6,500 shares for an estimated $1,549,795
J ROBERT KERREY has made 0 purchases and 5 sales selling 5,638 shares for an estimated $983,920.
NADJA WEST sold 3,000 shares for an estimated $532,050

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive THC Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$THC Hedge Fund Activity

We have seen 283 institutional investors add shares of $THC stock to their portfolio, and 344 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP added 1,209,118 shares (+106.5%) to their portfolio in Q1 2026, for an estimated $228,172,657
AQR CAPITAL MANAGEMENT LLC removed 813,951 shares (-36.1%) from their portfolio in Q1 2026, for an estimated $153,600,693
GLENVIEW CAPITAL MANAGEMENT, LLC removed 798,825 shares (-34.4%) from their portfolio in Q1 2026, for an estimated $150,746,265
NUVEEN, LLC removed 675,646 shares (-58.5%) from their portfolio in Q1 2026, for an estimated $127,501,156
KHROM CAPITAL MANAGEMENT LLC removed 504,279 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $95,162,490
QUBE RESEARCH & TECHNOLOGIES LTD added 499,399 shares (+324.4%) to their portfolio in Q1 2026, for an estimated $94,241,585
CAPITAL WORLD INVESTORS added 491,957 shares (+inf%) to their portfolio in Q1 2026, for an estimated $92,837,205

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$THC Government Contracts

We have seen $270,000 of award payments to $THC over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

STERILE PROCESSING SERVICES: $135,000

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$THC Congressional Stock Trading

Members of Congress have traded $THC stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $THC stock by members of Congress over the last 6 months:

REPRESENTATIVE JONATHAN L. JACKSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 04/20, 04/15, 02/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$THC Price Targets

Multiple analysts have issued price targets for $THC recently. We have seen 13 analysts offer price targets for $THC in the last 6 months, with a median target of $252.0.

Here are some recent targets:

Andrew Mok from Barclays set a target price of $240.0 on 07/09/2026
Ryan Langston from TD Cowen set a target price of $233.0 on 06/22/2026
Michael Ha from Baird set a target price of $210.0 on 05/05/2026
Raj Kumar from Stephens & Co. set a target price of $260.0 on 05/04/2026
Stephen Baxter from Wells Fargo set a target price of $213.0 on 05/01/2026
Matthew Gillmor from Keybanc set a target price of $225.0 on 05/01/2026
Jason Cassorla from Guggenheim set a target price of $252.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.